ClinicalTrials.Veeva

Menu

TEG 6s® for Perioperative Monitoring of Platelet Function During Cardiopulmonary Bypass for Cardiac Surgery (TEG-PM)

A

Assistance Publique - Hôpitaux de Paris

Status

Terminated

Conditions

Cardiopulmonary Bypass

Treatments

Device: TEG®6S device with its Platelet mapping® cartridge

Study type

Observational

Funder types

Other

Identifiers

NCT04746560
APHP201216

Details and patient eligibility

About

Excessive bleeding is common during cardiopulmonary bypass (CPB) for cardiac surgery. This may result from the systemic activation of the coagulation pathway and the acquired platelet dysfunction during the procedure. This study aims to compare the diagnostic performances of the TEG®6S device and its Platelet mapping® cartridge to those of the "gold standard" tests (light transmittance aggregometry and Multiplate®) for platelet function monitoring in patients undergoing CPB for cardiac surgery.

Full description

Excessive bleeding is common during cardiopulmonary bypass (CPB) for cardiac surgery. This may result from the systemic activation of the coagulation pathway and the acquired platelet dysfunction during the procedure. This study aims to compare the diagnostic performances of the TEG®6S device and its Platelet mapping® cartridge to those of the "gold standard" tests (light transmittance aggregometry and Multiplate®) for platelet function monitoring in patients undergoing CPB for cardiac surgery.

Enrollment

6 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients scheduled to undergo cardiopulmonary bypass
  • Informed consent

Exclusion criteria

  • Age <18 years
  • Pregnant women
  • Emergency surgery
  • Cardiac surgery without CPB
  • thrombocytopenia <100000/mmm3

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems